Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care |
| Investment focus | Equity, World, Health Care, Social/Environmental |
| Fund size | EUR 243 m |
| Total expense ratio | 0.18% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | Yes |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 13.13% |
| Inception/ Listing Date | 20 September 2022 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | Amundi ETF |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | HSBC Securities Services (Ireland) DAC |
| Investment Advisor | |
| Custodian Bank | HSBC Bank PLC |
| Revision Company | - |
| Fiscal Year End | 31 December |
| Swiss representative | NO |
| Swiss paying agent | NO |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | Yes |
| Securities lending counterparty |
| Eli Lilly & Co. | 11.05% |
| AbbVie, Inc. | 6.91% |
| Merck & Co., Inc. | 4.98% |
| AstraZeneca PLC | 4.74% |
| UnitedHealth Group | 4.72% |
| Novartis AG | 4.28% |
| Roche Holding AG | 4.24% |
| Amgen, Inc. | 3.31% |
| Thermo Fisher Scientific | 3.27% |
| Gilead Sciences, Inc. | 2.87% |
| United States | 67.06% |
| United Kingdom | 6.56% |
| Switzerland | 5.87% |
| Japan | 4.46% |
| Other | 16.05% |
| Health Care | 91.78% |
| Consumer Discretionary | 0.95% |
| Other | 7.28% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| 0.00 € | 0.00 € | View offer** | |
| 0.00 € | 0.00 € | View offer* | |
| 0.00 € | 0.00 € | View offer* | |
| 0.00 € | 0.00 € | View offer* | |
| 0.00 € | 0.00 € | View offer* |
| Broker | Rating | Order fee | ETF savings plans | |
|---|---|---|---|---|
| 0.00 € | 3199 | View offer** | |
| 0.00 € | 2611 | View offer* | |
| 0.00 € | 1868 | View offer* | |
| 1.00 € | 2629 | View offer* | |
| 0.00 € | 2276 | View offer* |
| YTD | -3.80% |
| 1 month | +4.41% |
| 3 months | -5.39% |
| 6 months | -5.88% |
| 1 year | +7.19% |
| 3 years | +8.15% |
| 5 years | - |
| Since inception (MAX) | +8.80% |
| 2025 | +0.35% |
| 2024 | +7.74% |
| 2023 | +2.15% |
| 2022 | - |
| Volatility 1 year | 13.13% |
| Volatility 3 years | 12.90% |
| Volatility 5 years | - |
| Return per risk 1 year | 0.55 |
| Return per risk 3 years | 0.20 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -12.07% |
| Maximum drawdown 3 years | -22.59% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -22.59% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | WELS | - - | - - | - |
| Euronext Paris | EUR | GLHL | GLHL FP IWELS | GLHL.PA IWELSEURINAV=SOLA | BNP Paribas Arbitrage |
| SIX Swiss Exchange | USD | WEL9 | WEL9 SW WEL9USIV | WEL9.S IWEL9USDINAV=SOLA | BNP Paribas Arbitrage |
| XETRA | USD | WEL9 | WEL9 GY WEL9USIV | WELSGUSD.DE IWEL9USDINAV=SOLA | BNP Paribas Arbitrage |
| XETRA | EUR | WELS | WELS GY IWELS | WELSG.DE IWELSEURINAV=SOLA | BNP Paribas Arbitrage |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) | 122 | 0.18% p.a. | Distributing | Full replication |